May 10, 2021
Not intended for U.S. and UK Media - American College of Cardiology’s 70th Annual Scientific Session (ACC.21):
Bayer announces two late-breaking presentations which include data from FIDELIO-DKD (finerenone) and VOYAGER PAD (Xarelto™) Phase III studies
